SenesTech Aktie

At the Lytham Partners Summit, SenesTech presented an operational realignment completed in about 200 days that led to record revenues, record gross profits and improved margins for the quarter. E‑commerce revenues nearly tripled, subscription revenues nearly doubled, and the company reduced monthly cash burn, bringing cash‑flow breakeven into view. Management is building two growth engines — a restructured e‑commerce business and a structured B2B sales organization — and sees scaling potential without substantial additional investment. » More on de.investing.com

SenesTech has signed a distribution agreement with Animal and Garden House to introduce its Evolve rodent birth-control product in Bermuda. The product aims to reduce rodent populations through fertility control instead of lethal rodenticides and can supplement or replace existing pest-control programs. The expansion, CEO Michael Edell said, aligns with Bermuda’s environmental protection focus; the company is already active in the U.S. Virgin Islands and Belize. SenesTech most recently reported a market capitalization of $8.16 million, annual revenue of $2.23 million and growth of 15.67%, while analysts note undervaluation and increased cash burn associated with the expansion. » More on de.investing.com

SenesTech reported a 2% revenue increase in the first quarter of 2026 to $493,000 and a record gross margin of 68.6%. Direct management of the Amazon account led to a 42% rise in D2C revenue; subscription revenues grew 44%. Management sees long-term benefits from the sales shift and expansion of the subscription model, but warned of short-term revenue disruptions. The stock fell about 4% in premarket trading. » More on de.investing.com